Anderson Raymond (CIK 1362489) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-28). Recent activity: Buy MNPR (1,402 shares), Buy MNPR (1,740 shares), Sell MNPR (694 shares), Sell MNPR (646 shares), Sell MNPR (1,802 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Buy | 1,402 | $42,060 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Buy | 1,740 | $52,200 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 694 | $76,368 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 646 | $71,751 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 1,802 | $203,716 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 694 | $76,368 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 646 | $71,105 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 1,802 | $203,716 |
来源：SEC Form 4 申报文件 · 截至 2026-08-28